Gladstone-UCSF Institute of Genomic Immunology Seminar
Monday, November 18, 2024

Kristen Hege, MD

Independent Board Member, Mersana, Adaptimmune, and Kelonia; Former Clinical Professor of Medicine in Hematology, UC San Francisco; SVP Early Clinical Development, Hematology, Oncology and Cell Therapy, Bristol Myers Squibb

Kristen Hege retired from her biopharma executive role at Bristol Myers Squibb (BMS) and her academic hematology practice at UC San Francisco in 2023 to pursue her lifelong dream of thru hiking the 2,650-mile Pacific Crest Trail from Mexico to Canada.

In this unique presentation, she reflects on her pioneering 25-year history with research and development of CAR-T cells, from the dawn of this breakthrough field at Cell Genesys, a startup Bay Area biotech company in the 1990s, to Celgene, and ultimately BMS where she led the development of Abecma, the first BCMA targeted CAR-T cell approved for multiple myeloma. She will also share her Pacific Crest Trail story and reflections on leadership lessons learned from this grand adventure that should resonate with all who pursue high-risk endeavors in science and medicine.

Details

Dates
November 18, 2024
Time
1:00-1:50pm PST
Location
Mahley Auditorium & Online
Audience
Gladstone and UCSF
Contact(s)







The Gladstone-UCSF Institute of Genomic Immunology Seminar Series showcases speakers at the intersection of genomic technology and immunology research with an aim to engineer the human immune system for therapeutic benefit. Speakers span technology development, synthetic biology, bioengineering, and the development and clinical application of immunotherapy. These talks are open to the Gladstone and UCSF communities.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.